IL15 and neoplasm: HepG2 and PLC/PRF/5 HCC tumour cells were incubated with the indicated concentrations of avelumab or cetuximab as indicated prior to co-culture with healthy donor NK cells that had been primed overnight with 1 ng/mL IL-15.